See all the latest videos and articles patriots need to watch and read at Discern.tv.
An HIV vaccine. (Mujahid Safodien/AFP via Getty Images) Companies have halted an advanced trial of an HIV vaccine because the shot was found to not prevent infection.
Results from the stage 3 trial led to the determination that the vaccine “was not effective in preventing HIV infection compared to placebo among study participants,” Johnson & Johnson and its partners said in a statement.
The vaccine, dubbed Mosiaco, was developed by Janssen, a Johnson & Johnson subsidiary.
The study’s Data and Safety Monitoring Board, or a group of independent experts that was monitoring the research, made the determination.
The study is being discontinued because of the determination, Johnson & Johnson said.
“We are disappointed with this outcome and stand in solidarity with the people and communities vulnerable to and affected by HIV,” Dr. Penny Heaton, an executive at Janssen, said in a statement.“We remain steadfast in our commitment to advancing innovation in HIV, and we hope the data from Mosaico will provide insights for future efforts to develop a safe and effective vaccine,” Heaton added.The study was launched in 2019 with funding from the U.S. government. It was designed to identify whether Janssen’s vaccine could prevent HIV infection in men.The U.S. National Institutes of Health, […]
Read the whole story at www.theepochtimes.com
Covid variant BA.5 is spreading. It appears milder but much more contagious and evades natural immunity. Best to boost your immune system with new Z-Dtox and Z-Stack nutraceuticals from our dear friend, the late Dr. Vladimir Zelenko.